Morning Breakouts

Latest KFF Health News Stories

FDA Approves Gene Therapy For Rare Disorder After Rejecting It 2 Years Ago

Morning Briefing

The therapy marketed as Kresladi was initially rejected in 2024 because of manufacturing concerns. It treats leukocyte adhesion deficiency type 1 (LAD-1), an ultra-rare disease — affecting about one in a million — that makes children vulnerable to life-threatening infections and can lead to death.

Safety Net Hospital Sees Temporary Shutdown Over Faulty Billing System

Morning Briefing

West Suburban Medical Center in Illinois has been facing difficulties with a new computerized billing system for a year, and that has translated into a lack of revenue to cover normal operating expenses and has led to its temporary closure. Plus: Health care AI company OpenEvidence has just launched a feature to automate the medical coding and billing process.

Senate Votes To Fund DHS But Not ICE After Killings Of Good, VA Nurse Pretti; House Republicans Rebuff Deal

Morning Briefing

Conservative House Republicans derided the deal for omitting money for Immigrations and Customs Enforcement and Border Patrol, the two agencies responsible for carrying out President Trump’s immigration crackdown, The New York Times reported.

In Anti-DEI Push, Trump Officials Demand Data From 3 Medical Schools

Morning Briefing

The Department of Justice has opened inquiries into how race might be considered in the admissions policies at Stanford, Ohio State, and the University of California, San Diego. The department also sued NewYork-Presbyterian and launched an inquiry over trans prisoners in California and Maine.

Michigan Child With Measles May Have Exposed ER Visitors As Outbreak Grows

Morning Briefing

Seven cases are under investigation; all of the people involved were unvaccinated against measles, CBS News reported. The emergency room treatment area of Trinity Health Ann Arbor Hospital in Ypsilanti was potentially exposed to the virus on March 21.

FDA Approves Hunter Syndrome Drug On Heels Of Similar Drug Rejections

Morning Briefing

Last month, the FDA rejected a Hunter syndrome gene therapy from Regenxbio over a lack of clinical data. Denali Therapeutics’ drug is a form of enzyme replacement therapy — not a gene therapy — that can enter the brain and slow the cognitive decline affecting two-thirds of patients.

Aetna, Elevance, Humana May Be Sued In Alleged Kickback Scheme, Judge Says

Morning Briefing

The insurers are accused of paying to have customers directed to their Medicare Advantage plans and of paying brokers to limit sign-ups of people with disabilities. The companies deny any wrongdoing.

Cord Blood Bank Sued By Two States Over Misleading Advertising

Morning Briefing

The company Cord Blood Registry is being sued by the attorneys general of Texas and Arizona over claims about the medical value of storing newborn cord blood, while charging new parents thousands of dollars. The lawsuits ask CBR to remove the false ads and repay families.

CDC In Leadership Limbo As Trump Misses Deadline To Nominate Director

Morning Briefing

Jay Bhattacharya will continue to lead the agency while the administration searches for a permanent director. About six contenders are still under consideration, The Washington Post reports. Also, a month after Casey Means’ confirmation hearings, she still has not secured the surgeon general post.

Jury Finds Meta, YouTube Liable In Landmark Social Media Addiction Trial

Morning Briefing

Jurors ruled that Meta and YouTube were negligent and awarded the plaintiff $6 million in damages. Meanwhile, The New York Times reports on an Irish village making a “phone-free childhood” happen.

Isolation Linked To Lower Uptake Of Preventive Care, Higher Death Rates

Morning Briefing

A lack of social connections has been linked to higher all-cause death rates. Physical and social isolation were also tied to financial difficulty, including food insecurity and problems paying bills.

Belgian Drugmaker UCB To Build Factory Outside Atlanta, Add 330 Jobs

Morning Briefing

The rapidly growing company will spend $2 billion on the suburban Atlanta plant, marking a major expansion into the U.S. Other industry news is on insulin pricing, doctors’ drug kickbacks, and more.

Experts Worry ‘Hib,’ A Deadly Pediatric Illness, Could Make A Comeback

Morning Briefing

Pediatricians are expressing alarm that Haemophilus influenzae type b, or Hib, could be making a return as vaccine hesitancy rises. According to MedPage Today, serious cases are being reported in California, New York, Florida, and elsewhere. Also in the news: measles, alpha-gal syndrome, RSV, and more.

Children’s Mental Health Suffered On Meta’s Platforms, N.M. Jury Determines

Morning Briefing

Jurors in New Mexico concluded that Meta violated parts of the state’s Unfair Practices Act and engaged in “unconscionable” trade practices that compromised children’s safety, the AP reported.